CJ-15,801, a novel antibiotic from a fungus, Seimatosporium sp

Related Experiment Video

Updated: Oct 2, 2026

Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans
07:32

Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans

Published on: March 19, 2015

Y Sugie1, K A Dekker, H Hirai

  • 1Exploratory Medicinal Sciences, PGRD, Nagoya Laboratories, Pfizer Pharmaceuticals, Inc., Aichi, Japan. Yutaka.Sugie@japan.pfizer.com

The Journal of Antibiotics
|February 23, 2002
PubMed

Insights

A new antibiotic, CJ-15,801, derived from fungus, effectively combats multi-drug resistant Staphylococcus aureus. This discovery offers a potential new weapon against challenging bacterial infections.

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Drug Discovery

Background:

  • The rise of multi-drug resistant (MDR) bacteria, particularly Staphylococcus aureus, poses a significant global health threat.
  • There is an urgent need for novel antibiotics with unique mechanisms of action to overcome existing resistance.

Purpose of the Study:

  • To isolate and characterize a novel antibiotic compound from a fungal source.
  • To evaluate the efficacy of the isolated compound against clinically relevant MDR Staphylococcus aureus strains.

Main Methods:

  • Isolation of the antibiotic CJ-15,801 from the fermentation broth of Seimatosporium sp. CL28611.
  • Structural elucidation of CJ-15,801 using advanced spectroscopic analyses.
  • Determination of Minimum Inhibitory Concentrations (MICs) against MDR Staphylococcus aureus isolates.

Main Results:

  • A novel antibiotic, CJ-15,801, was successfully isolated and identified as a pantothenic acid analog.
  • CJ-15,801 possesses an alpha,beta-unsaturated carboxylic acid moiety.
  • The compound demonstrated potent inhibitory activity against MDR Staphylococcus aureus strains, with MIC values ranging from 6.25 to 50 microg/ml.

Conclusions:

  • CJ-15,801 represents a promising new antibiotic candidate for combating MDR Staphylococcus aureus infections.
  • The unique structure of CJ-15,801 may offer a novel approach to circumvent existing bacterial resistance mechanisms.
  • Further investigation into the mechanism of action and in vivo efficacy of CJ-15,801 is warranted.

More Related Videos

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Related Concept Videos

Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...